Jahanzeb K. khan

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Nephrology Fellow

UAMS

Also affiliated: Gomal University (2014–2017); Dow University of Health Sciences (2021–2022); Baptist Health Foundation (2021)

4 h-index 16 pubs 59 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jahanzeb Khan's research focuses on health disparities and outcomes, particularly within the context of type 2 diabetes and its associated complications among Pakistani Muslim populations. He has investigated asymptomatic urinary tract infections and their risk factors in this demographic, as well as the safety and efficacy of specific diabetes medications like Empagliflozin and Semaglutide. Khan's work also extends to exploring potential adverse events related to medical interventions, including a case study on a membranous nephropathy linked to a COVID-19 vaccine and a case report on Semaglutide potentially causing focal segmental glomerulosclerosis.

His research interests are further indicated by publications on environmental concerns, including heavy metal contamination in groundwater and the efficacy of adsorbents for metal removal. Khan's academic contributions are reflected in his h-index of 7, with 25 publications and 189 citations. He collaborates with colleagues at the University of Arkansas for Medical Sciences, including Luis A. Juncos, Umair Ali, Gerry Ezell, and Wahida Rashid.

Metrics

h-index: 4
Publications: 16
Citations: 59

Positions

Nephrology Fellow publications 2023

University of Arkansas for Medical Sciences Institution web page

Selected Publications

Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS) (2023)

Journal of the American Society of Nephrology 2 citations DOI OpenAlex
A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine (2022)

Cureus 7 citations DOI OpenAlex